Get A Quote

GMP

GMP is that part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.
BOC Sciences has been committed to continuously and consistently assuring GMP compliance throughout our day-to-day operations across all sites. In the past years, our GMP production sites are designed in strict accordance to US-FDA guidelines for GMP manufacturing and have passed US-FDA inspections many times. The total available reaction volume of GMP facility is about hundreds of tons.

gmp-p1.jpg
  • gmp-p2.jpg
  • gmp-p3.jpg

Our GMP fermentation teams work in close collaboration with our development staff, they are routinely trained to operate in full compliance with the GMP.

Through all stages of product development, we always have close working relationships with our clients. Outsourcing with BOC Sciences for your project will enable you to grow your business at the more economical way.

Our quality program for GMP manufacturing

  • Standard Operating Procedures and strict Document Control
  • Regular Employee Training and Facility Maintenance, Equipment Maintenance, and Calibration
  • Continues optimization process in GMP production
  • Enhancement of review preparation and production tracking
  • Starting Raw Material and Component Control
  • Change Control and Risk Management

Quality by Design (QbD)

The ICH Q8 guideline states that quality should be built in by design instead of tested into products. BOC Sciences is committed to apply QbD approach on every single batch of our product. Design of Experiment (DOE), Risk Assessment Tools (RAT), Process Analytical Technologies (PAT) are employed all along in the lifecycle of our formulation development to improve the quality, safety and efficacy of drug product:

  • Determine the Quality Target Product Profile (QTPP) of the specific product
  • Identification of the Critical Quality Attributes (CQAs) of the drug and the Critical Process Parameters of the process
  • Potential formulation strategy suggestions with QbD Principles
  • Conduct the Preliminary Risk Assessment
  • Analyze the risks of the selected CQAs and CPPs for each unit operation
  • Choose the appropriate control strategies for selected CQAs and CPPs
  • Establish the Design Space

Fermentation Products

Agricultural

Agricultural

Crop Protection, Biofertilizers

Animal Health

Animal Health

Veterinary Antibiotics, Probiotics for Animals

Antibiotics

Antibiotics

Antimicrobial Agents, Fermented Antibiotics

Antidiabetic

Antidiabetic

Glucose Control, Insulin Mimics

Antifungal

Antifungal

Fungal Inhibitors, Fermented Antifungals

Antineoplastic

Antineoplastic

Cancer Treatment, Tumor Suppressors

Antioxidative

Antioxidative

Free Radical Scavengers, Antioxidant Fermentation

Antiviral

Antiviral

Virus Inhibition, Fermented Antivirals

Bioactive by-products

Bioactive by-products

Secondary Metabolites, Natural Extracts

Cyclosporin Analogue Set

Cyclosporin Analogue Set

Immunosuppressants, Cyclosporin Derivatives

Enzyme inhibitors

Enzyme inhibitors

Protease Inhibitors, Enzyme Modulators

Mycotoxins

Mycotoxins

Toxin Control, Mycotoxin Removal

Raw Materials of Healthcare Products

Raw Materials of Healthcare Products

Pharmaceutical Fermentation, Bioactive Ingredients

Tacrolimus Analogue Set

Tacrolimus Analogue Set

Immunosuppressive Compounds, Tacrolimus Derivatives

Get In Touch

Copyright © 2025 BOC Sciences. All rights reserved.

cartIcon
Inquiry Basket